DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1

第15回DIA日本年会

未曾有の変革の時代、イノベーション創出とグローバルヘルスへの貢献を、どのような連携の下で進めていくか

[V3-S3] TransCelerate: Innovation through Collaboration

Session Chair(s)

Norie  Miki-Yasuda, PhD

Norie Miki-Yasuda, PhD

Head of Clinical Operations Europe, Canada, Australia & New Zealand

Boehringer Ingelheim Pharma GmbH & Co. KG, Germany

“If you want to go fast, go alone; if you want to go far, go together.” Harnessing the power of collaboration can truly alter the healthcare landscape. This session will present TransCelerate’s perspectives around the next generation of collaborations. How will we need to work together differently as regulators, sponsors, patients, sites, and technologists are brought together? How can collaborations defy the bounds of innovation and accelerate disease prevention, diagnosis, treatment, and?—?ultimately?—?cures? This thought-provoking conversation will bring together a diverse panel of senior executives from TransCelerate Member Companies to discuss the many solutions that have been developed across 19 companies to evolve the clinical trials paradigm. Attendees will learn about how TransCelerate has been solving challenges with Regulators in the Pharmacovigilance space, redefining the Site Investigator experience through novel technologies, and utilizing model frameworks for eConsent and eLabels to progress the industry towards digitally-supported, patient-centric trials.

Speaker(s)

Gareth H Morgan, MBA, MS

An Overview of TransCelerate BioPharma, Inc.

Gareth H Morgan, MBA, MS

Shionogi USA Inc., United States

Vice President, Management & Clinical Development

Toshiharu  Sano, RPh

TransCelerate Activities in Japan

Toshiharu Sano, RPh

Japan Pharmaceutical Manufacturers Association, Japan

Vice-Chairperson, Drug Evaluation Committee

Ken  Kubota, PhD

Key Initiative Update: Pharmacovigilance

Ken Kubota, PhD

Astellas Pharma Inc., United States

Vice President for Pharmacovigilance Operations

Kouichi  Mitsuhashi

Key Initiative Update: SIP (Shared Investigator Platform)

Kouichi Mitsuhashi

MSD K.K., Japan

RBSL, Clinical Operations

Yosuke  Chiyomori

eLabels in Clinical Supplies

Yosuke Chiyomori

Eli Lilly Japan K.K., Japan

Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。